We are live on ! Find out more
USNA icon

Usana Health Sciences

130 hedge funds and large institutions have $542M invested in Usana Health Sciences in 2013 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 43 increasing their positions, 51 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.22% more ownership

Funds ownership: 103.06%103.28% (+0.22%)

6% less funds holding

Funds holding: 139130 (-9)

12% less capital invested

Capital invested by funds: $616M → $542M (-$74.2M)

16% less repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 51

47% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 19

Holders
130
Holders Change
-9
Holders Change %
-6.47%
% of All Funds
3.77%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
10
Increased
43
Reduced
51
Closed
19
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CIA
51
Capital Impact Advisors
Massachusetts
$1.61M +$1.64M +42,746 New
CS
52
Credit Suisse
Switzerland
$1.58M +$991K +25,904 +162%
GCP
53
GSA Capital Partners
United Kingdom
$1.46M +$207K +5,398 +16%
CIBC World Market
54
CIBC World Market
Ontario, Canada
$1.38M -$827K -21,602 -37%
MCM
55
Matarin Capital Management
New York
$1.38M +$462K +12,086 +49%
California Public Employees Retirement System
56
California Public Employees Retirement System
California
$1.36M -$302K -7,884 -18%
Allianz Asset Management
57
Allianz Asset Management
Germany
$1.36M +$542K +14,164 +65%
PP
58
PDT Partners
New York
$1.33M -$540K -14,106 -29%
DekaBank Deutsche Girozentrale
59
DekaBank Deutsche Girozentrale
Germany
$1.29M
Wellington Management Group
60
Wellington Management Group
Massachusetts
$1.27M +$9.49K +248 +0.7%
BIM
61
BlackRock Investment Management
Delaware
$1.25M -$35.4K -924 -3%
GF
62
Gerstein Fisher
New York
$1.15M +$116K +3,042 New
FQ
63
First Quadrant
California
$1.11M -$375K -9,800 -25%
Charles Schwab
64
Charles Schwab
California
$1.07M +$38.6K +1,008 +4%
CCMH
65
Cornerstone Capital Management Holdings
New York
$967K +$980K +25,600 New
Invesco
66
Invesco
Georgia
$919K -$935K -24,442 -50%
Wells Fargo
67
Wells Fargo
California
$859K -$3.53M -92,348 -80%
Bessemer Group
68
Bessemer Group
New Jersey
$847K
Two Sigma Advisers
69
Two Sigma Advisers
New York
$835K -$536K -14,000 -39%
California State Teachers Retirement System (CalSTRS)
70
California State Teachers Retirement System (CalSTRS)
California
$820K +$7.65K +200 +0.9%
SO
71
STRS Ohio
Ohio
$786K -$45.9K -1,200 -5%
Ameriprise
72
Ameriprise
Minnesota
$726K -$142K -3,708 -16%
State Board of Administration of Florida Retirement System
73
State Board of Administration of Florida Retirement System
Florida
$708K -$200K -5,226 -22%
AllianceBernstein
74
AllianceBernstein
Tennessee
$695K -$252K -6,588 -26%
TA
75
Teachers Advisors
New York
$665K -$1.95M -51,010 -74%

USNA Hedge Fund Activity: Q4 2013 in Review

130 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q4 2013, worth a combined $542M — down 12% from $616M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of USNA and 10 opened new positions — a net loss of 9 holders — while 51 trimmed existing stakes and 43 added.

The largest buyer was Renaissance Technologies, adding an estimated $5.44M. The largest seller was LSV Asset Management, cutting an estimated $4.66M.

  • 130 institutional investors held Usana Health Sciences (USNA) as of Q4 2013, down from 139 in Q3 2013.
  • Funds reported $542M of Usana Health Sciences stock for Q4 2013, down 12% quarter-over-quarter.
  • 10 funds opened new Usana Health Sciences positions in Q4 2013 and 19 closed out, a net change of -9 holders.
  • The largest Usana Health Sciences buyer in Q4 2013 was Renaissance Technologies, an estimated $5.44M added.
  • The largest Usana Health Sciences seller in Q4 2013 was LSV Asset Management, an estimated $4.66M sold.

Based on aggregated 13F filings for Q4 2013.